Insights

Strategic partnerships Second Genome has a track record of collaborating with industry leaders and academic institutions (e.g., Arena Pharmaceuticals, Virginia Commonwealth University, Gilead) to advance microbiome-based biomarkers and therapies. This indicates receptiveness to external partnerships and potential co-development or licensing opportunities for diagnostic biomarkers and companion diagnostics.

Clinical pipeline The company is actively advancing a pipeline of novel microbiome-derived therapies and biomarkers, including preclinical data for SG-5-00455, signaling ongoing R&D activity. This creates opportunities to position services around biomarker discovery, platform validation, and translational research support for late-stage programs.

Platform leverage Second Genome emphasizes a proprietary discovery platform with cross-industry applicability (healthcare, nutrition, agriculture). Sellers can target platform-as-a-service offerings, data analytics, and high-throughput microbiome profiling to accelerate partner programs and broaden use cases beyond human therapeutics.

Funding signals With $62M in funding and revenue under $1M, the company is likely in a growth-focused phase seeking strategic investments, partnerships, and contract research opportunities to scale its platform, making it a fit for collaborations, sponsored research agreements, and scalable data-generation agreements.

Operational readiness A small team with a modern tech stack (AWS, New Relic, Jira, Trello, BambooHR) suggests agility and potential for rapid onboarding of partner projects. This indicates suitability for quick-start collaborations, joint development ventures, and flexible service delivery models.

Similar companies to Second Genome Inc.

Second Genome Inc. Tech Stack

Second Genome Inc. uses 8 technology products and services including Amazon Web Services, Amazon Simple Email Service, Google Workspace, and more. Explore Second Genome Inc.'s tech stack below.

Media & News

Second Genome Inc.'s Email Address Formats

Second Genome Inc. uses at least 2 email formats:
Second Genome Inc. Email FormatsExamplePercentage
First@secondgenome.comJohn@secondgenome.com
88%
Last@secondgenome.comDoe@secondgenome.com
12%

Frequently Asked Questions

What is Second Genome Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Second Genome Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Second Genome Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Second Genome Inc.'s official website is secondgenome.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Second Genome Inc. generate?

Minus sign iconPlus sign icon
As of October 2026, Second Genome Inc.'s annual revenue is estimated to be <$1M.

What is Second Genome Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Second Genome Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Second Genome Inc. have currently?

Minus sign iconPlus sign icon
As of October 2026, Second Genome Inc. has approximately 4 employees across 2 continents, including North America and Europe. Key team members include Chief Scientific Officer: P. G. L., Vice-President: S. V. and Director Research: M. S. Explore Second Genome Inc.'s employee directory with LeadIQ.

What industry does Second Genome Inc. belong to?

Minus sign iconPlus sign icon
Second Genome Inc. operates in the Biotechnology Research industry.

What technology does Second Genome Inc. use?

Minus sign iconPlus sign icon
Second Genome Inc.'s tech stack includes Amazon Web Services, Amazon Simple Email Service, Google Workspace, Atlassian Jira, DocuSign, Trello, New Relic and BambooHR.

What is Second Genome Inc.'s email format?

Minus sign iconPlus sign icon
Second Genome Inc.'s email format typically follows the pattern of First@secondgenome.com. Find more Second Genome Inc. email formats with LeadIQ.

How much funding has Second Genome Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2026, Second Genome Inc. has raised $62M in funding. The last funding round occurred on Oct 03, 2017.

When was Second Genome Inc. founded?

Minus sign iconPlus sign icon
Second Genome Inc. was founded in 2009.
Second Genome Inc. logo

Second Genome Inc.

Biotechnology ResearchCalifornia, United States2-10 Employees

Second Genome operates in biotechnology research with a focus on the microbiome, translating scientific advances into medicines and other novel products. It is developing a pipeline of therapies for serious diseases and pursuing breakthroughs across healthcare, nutrition, and agriculture through a proprietary discovery platform. The company also positions itself as an expert partner for microbiome research projects, collaborating with leading corporations, academic institutions, and government organizations to move emerging science toward practical applications.

Based in South San Francisco, California, the company maintains a small team focused on its research and development efforts. In February 2022, Second Genome announced preclinical data for SG-5-00455, a development candidate, reflecting ongoing progress in its program portfolio.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2009
Employees
2-10

Section iconFunding & Financials

  • $62M

    Second Genome Inc. has raised a total of $62M of funding over 4 rounds. Their latest funding round was raised on Oct 03, 2017 as a Grant.

  • <$1M

    Second Genome Inc.'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.